University of Nebraska among world's top 100 in earning U.S. patents

by Charlie Litton, UNeMed | June 25, 2020

Image with caption: Michael Dixon, Ph.D.

Michael Dixon, Ph.D.

For the third straight year, the University of Nebraska system is ranked among the top 100 academic institutions worldwide in earning U.S. patents.

A newly released report from the National Academy of Inventors and Intellectual Property Owners Association lists the NU system at No. 65, a 14-spot improvement from the previous year. The ranking reflects the 44 patents granted in 2019 by the U.S. Patent and Trademark Office to the University's technology transfer offices: UNeMed Corp. and her sister office NUtech Ventures in Lincoln. UNeMed is the technology transfer office for UNMC and UNO.

"Innovation and discovery are core values of UNMC and UNO," said Jeffrey P. Gold, M.D., chancellor of both universities. "To be among the top 100 universities worldwide to receive U.S.-issued patents is a strong testament to the culture of innovation we value throughout the University of Nebraska, and especially on our UNMC and UNO campuses. It also speaks highly of the talent and creativity among our faculty, staff and students, who, each day, strive to improve our world."

"The University of Nebraska's culture of innovation grows stronger and stronger year after year" said UNeMed president and CEO, Michael Dixon, Ph.D. "The ongoing creativity from our inventors only proves it, and will soon pay dividends not just to our overall health, but throughout the ecosystem as the backbone of some new high-growth, high-wage Nebraska companies."

Patents allow UNeMed and NUtech Ventures to work with faculty, staff and students to bring research and innovations in areas like biotechnology, agriculture, health care, engineering and others to the marketplace. The results are new startup companies, jobs and university-licensed products that grow the economy and improve quality of life.

"It's always gratifying to see the University of Nebraska land on lists like this," Dr. Dixon said. "But it's also important to realize that patents are but one tool for us as we try to help these discoveries and innovations move forward. Patents are great, but that is just the beginning for us and NUtech."

Often, a patent can attract collaborative partnerships that help finance and support additional research and development of University technologies. Right now, 71 percent of UNeMed's patent portfolio is licensed for further development.

Of UNeMed's 21 issued U.S. patents last year, 17 were licensed to nine different companies.

"What that means is that's 17 technologies that are getting the additional support they need for further development," Dr. Dixon said. "In a nutshell, that's why we exist: To help push University innovations as far down the development road as possible."

Among the companies that licensed UNeMed's issued patents, seven are Nebraska startups, including Radux Devices.

Radux developed a device that helps physicians avoid the muscoskeletal stresses and injuries common for interventional radiologists. Developed by Greg Gordon, M.D., a former UNMC interventional radiologist, the device improves the ergonomics of catheter management during fluoroscopic procedures. It now serves as the basis for Omaha-based startup company Radux Devices, which is manufacturing and selling multiple FDA-approved medical devices that help improve safety and quality for both patients and physicians.

Seven patents are related to the groundbreaking surgical robots created by co-inventors Shane Farritor, Ph.D., and former UNMC surgeon, Dmitry Oleynikov, M.D. So far, Virtual Incision has raised more than $50 million and already has succeeded in early human trials as it approaches FDA clearance.

Another licensed and patented technology also is approaching FDA approval: A hemodialysis catheter invented by nephrologist Marius Florescu, M.D. Licensed to Chrysalis Medical, the new catheter contains a small balloon that can expand to break up the kind of tissue that often forces physicians to replace catheters.

Yet another licensed technology that earned patents in 2019 was in collaboration with Vireo Systems, which operates a manufacturing facility in Plattsmouth, Nebraska. Vireo makes and sells health supplements such as UNMC's creatine ethyl-ester and creatine hydrochloride compounds. They are both sold globally under the brand names "CON-CRET" and "AminoActiv," respectively.

Two more patents are continued testament to the creativity of Sam Sanderson, Ph.D., who died suddenly in 2017. His startup company, Prommune, along with his co-inventor, Joe Vetro, Ph.D., are developing immune stimulating peptides that can boost the human immune system to fight deadly infections.

"All these technologies will help improve the quality of life for countless people over the coming years," Dr. Dixon said. "That's fantastic, but another result is the juice they add to Nebraska's economic engine. Those home-brewed innovations create new industry and produce the kind of high-paying jobs that can really boost the local and state economy."


Fill out the following and your comment will post once it has been approved.

Name (Required)

Email (Required)

Thank you, your comment will appear below once it has been approved.

Kris Morrissey
June 25, 2020 at 2:08 PM

UNeMed is doing great things! Proud to call you colleagues.

Babu Guda
June 25, 2020 at 10:12 AM

Congratulations Mike! Your team is awesome.

Tom O’Connor
June 25, 2020 at 9:05 AM

Great work, Team UNeMed! Super impressive.

Linda Miller
June 25, 2020 at 8:02 AM

Congratulations to Michael and the amazing community of innovators at UNMC. The efforts of UneMed to drive academic/industry partnerships and create a pathway to commercialization is certainly exciting and vital to continued growth on campus.